Bone metastasis, skeletal-related events, and mortality in lung cancer patients: A Danish population-based cohort study

被引:123
作者
Cetin, Karynsa [1 ]
Christiansen, Christian Fynbo [2 ]
Jacobsen, Jacob Bonde [2 ]
Norgaard, Mette [2 ]
Sorensen, Henrik Toft [2 ]
机构
[1] Amgen Inc, Ctr Observat Res, Thousand Oaks, CA 91320 USA
[2] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark
关键词
Bone metastasis; Lung cancer; Cohort study; Mortality; Skeletal-related events; Population-based; US MEDICARE BENEFICIARIES; PROSTATE-CANCER; BREAST-CANCER; DISEASE; RISK;
D O I
10.1016/j.lungcan.2014.08.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To estimate the incidence rate of bone metastasis and subsequent skeletal-related events (SREs) (radiation to bone, spinal cord compression, fracture, and surgery to bone) in lung cancer patients and to quantify their impact on mortality. Materials and methods: We conducted a nationwide cohort study of patients diagnosed with lung cancer between 1999 and 2010 in Denmark. We computed the cumulative incidence (%) of bone metastasis and subsequent SREs (treating death as a competing risk) and corresponding incidence rates (per 1000 person-years). Survival was evaluated using the Kaplan-Meier method for three dynamic lung cancer patient cohorts-no bone metastasis; bone metastasis without SREs; and bone metastasis with SREs. Based on a Cox proportional hazards model, we computed mortality rate ratios (MRRs) comparing mortality rates between these patient cohorts, adjusting for age, comorbidity, stage, and histology. Analyses were conducted for the lung cancer patient cohort overall and by histologic subtype. Results: We identified 29,720 patients with incident lung cancer (median follow-up: 7.3 months). The 1-year cumulative incidence of bone metastasis was 5.9%, and the 1-year cumulative incidence of subsequent SREs was 55.0%. The incidence of bone metastasis and SREs was higher in patients with non-small cell lung cancer (NSCLC) versus SCLC. One-year survival was 37.4% in patients with no bone metastasis; 12.1% in patients with bone metastasis without SREs; and 5.1% in patients with both bone metastasis and SREs. When mortality rates between patients with bone metastasis with and without an SRE were compared, 2-month mortality rates were similar, but the >2-month adjusted MRR was 2.0 (95% confidence interval: 1.7-2.2). Conclusion: Bone metastases predict a poor prognosis in lung cancer patients. The majority of lung cancer patients with bone metastasis will also experience an SRE, which may further increase the rate of mortality. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:247 / 254
页数:8
相关论文
共 28 条
[1]   Prevention and Management of Bone Metastases in Lung Cancer A Review [J].
Al Husaini, Hamed ;
Wheatley-Price, Paid ;
Clemons, Mark ;
Shepherd, Frances A. .
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (02) :251-259
[2]   Bone matters in lung cancer [J].
Brodowicz, T. ;
O'Byrne, K. ;
Manegold, C. .
ANNALS OF ONCOLOGY, 2012, 23 (09) :2215-2222
[3]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[4]   Clinical features of metastatic bone disease and risk of skeletal morbidity [J].
Coleman, Robert E. .
CLINICAL CANCER RESEARCH, 2006, 12 (20) :6243S-6249S
[5]   The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer [J].
Delea, T ;
Langer, C ;
McKiernan, J ;
Liss, M ;
Edelsberg, J ;
Brandman, J ;
Sung, J ;
Raut, M ;
Oster, G .
ONCOLOGY, 2004, 67 (5-6) :390-396
[6]   Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer [J].
Di Maio, M ;
Gridelli, C ;
Gallo, C ;
Manzione, L ;
Brancaccio, L ;
Barbera, S ;
Robbiati, SF ;
Ianniello, GP ;
Ferraù, F ;
Piazza, E ;
Frontini, L ;
Rosetti, F ;
Carrozza, F ;
Bearz, A ;
Spatafora, M ;
Adamo, V ;
Isa, L ;
Iaffaioli, RV ;
Di Salvo, E ;
Perrone, F .
BRITISH JOURNAL OF CANCER, 2004, 90 (12) :2288-2296
[7]  
Engholm G, 2012, CANC INCIDENCE MORTA
[8]   NORDCAN - a Nordic tool for cancer information, planning, quality control and research [J].
Engholm, Gerda ;
Ferlay, Jacques ;
Christensen, Niels ;
Bray, Freddie ;
Gjerstorff, Marianne L. ;
Klint, Asa ;
Kotlum, Joanis E. ;
Olafsdottir, Elinborg ;
Pukkala, Eero ;
Storm, Hans H. .
ACTA ONCOLOGICA, 2010, 49 (05) :725-736
[9]   Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [J].
Ferlay, Jacques ;
Shin, Hai-Rim ;
Bray, Freddie ;
Forman, David ;
Mathers, Colin ;
Parkin, Donald Maxwell .
INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (12) :2893-2917
[10]   Epidemiology - When an entire country is a cohort [J].
Frank, L .
SCIENCE, 2000, 287 (5462) :2398-2399